Creative Edge Nutrition, Inc. (OTC Pink: FITX) (PINKSHEETS: FITX), today announced with great pleasure that our subsidiary CEN Biotech Inc. purchased a 25 acre site in Lakeshore, Ontario (approximately 1/4 mile from our main site). The site is located at 135 North Rear Rd. The site is nearly complete and we will call for pre-license inspection on it within a few weeks. This is an independent and separate application from our site at 20 North Rear Rd, Lakeshore, Ontario. This will also be a standalone fully functional facility; a smaller model of our building one site one standalone model. It will be a cGMP/ USP 797 facility and have a similar workflow model to our main site. We have applied for the license to grow and sell marijuana and will be applying for the license to grow hemp on the site and conduct hemp trials.
"We purchased the site with the intentions of operating a research and development facility with respect to strain genetics, new grow techniques and bio-medical research," commented Bill Chaaban, President & CEO. "It has been our intention to not only grow and sell medical marijuana, but to be leaders in the forefront of medical marijuana research; In particular, to further identify treatment modalities for specific disease states based on strain selection. We intend to develop and own the intellectual property."
Dr. Sam Alawieh, Dr. David Felten and their medical advisory board will be instrumental in this research.
For a video of the property, please view
About Creative Edge Nutrition, Inc.
Creative Edge Nutrition is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities. http://www.cenergynutrition.com and https://www.facebook.com/CenergyNutrition
About CEN Biotech
CEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition (OTC Pink: FITX) (PINKSHEETS: FITX) for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR). CEN Biotech Inc. has submitted a comprehensive application to become a licensed producer (LP) of dried marihuana for medicinal purposes and has received a ready-to-build approval from Health Canada.
FOR INVESTOR RELATIONS
SOURCE: Creative Edge Nutrition, Inc.